Syndax Pharmaceuticals Inc
Biopharma firm developing and commercializing first-in-class therapies for cancer patients.
SNDX | US
Overview
Corporate Details
- ISIN(s):
- US87164F1057
- LEI:
- Country:
- United States of America
- Address:
- 730 THIRD AVENUE, 10017 NEW YORK
- Website:
- https://syndax.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Syndax Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company that develops and commercializes innovative therapies for cancer patients. The company focuses on advancing first-in-class treatments in areas of significant unmet medical need, with a particular emphasis on conditions such as acute leukemia. Syndax's mission is to discover and develop transformative drugs by leveraging scientific approaches in epigenetics and immunomodulation. The firm aims to obtain regulatory approval and commercialize these novel therapies to extend and improve the lives of people with cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Syndax Pharmaceuticals Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Syndax Pharmaceuticals Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Syndax Pharmaceuticals Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
